ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
NexGel Inc

NexGel Inc (NXGL)

3.30
0.00
( 0.00% )
Actualizado: 09:42:56

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
3.30
Postura de Compra
3.20
Postura de Venta
3.30
Volume Operado de la Acción
22,116
3.14 Rango del Día 3.3958
1.7107 Rango de 52 semanas 3.55
Capitalización de Mercado [m]
Precio Anterior
3.30
Precio de Apertura
3.26
Última hora de negociación
09:45:46
Volumen financiero
US$ 73,637
Precio Promedio Ponderado
3.3296
Volumen promedio (3 m)
59,927
Acciones en circulación
6,790,777
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.10
Beneficio por acción (BPA)
-0.46
turnover
4.09M
Beneficio neto
-3.16M

Acerca de NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels a... NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company recognizes revenue from contract manufacturing. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
NexGel Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NXGL. The last closing price for NexGel was US$3.30. Over the last year, NexGel shares have traded in a share price range of US$ 1.7107 to US$ 3.55.

NexGel currently has 6,790,777 shares in issue. The market capitalisation of NexGel is US$22.41 million. NexGel has a price to earnings ratio (PE ratio) of -7.10.

NXGL Últimas noticias

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing Gross profit margin for the quarter was 43.6% compared to 28.2% in...

NEXGEL Announces $2,000,000 Registered Direct Offering

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...

NEXGEL to Participate in Upcoming October Investor Conferences

LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially

LANGHORNE, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection

LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical and over-the-counter (OTC) products including...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.02-0.6024096385543.323.422.9501842333.19638064CS
40.28549.467259337893.01463.552.671015023.14580193CS
120.4415.38461538462.863.552.4599273.00299773CS
260.9439.83050847462.363.551.84513862.84357653CS
521.4679.3478260871.843.551.7107355212.72964549CS
156-1.1-254.44.661.09716472.57834457CS
260-1.1-254.44.661.09716472.57834457CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WORXSCWorx Corporation
US$ 1.94
(97.96%)
99.02M
CRNCCerence Inc
US$ 5.30
(87.94%)
23.7M
SKKSKK Holdings Limited
US$ 7.32
(60.53%)
5.65M
IBGInnovation Beverage Group Limited
US$ 1.26
(59.25%)
4.2M
SURGSurgePays Inc
US$ 2.115
(44.86%)
11.62M
PYXSPyxis Oncology Inc
US$ 2.08
(-45.55%)
8.22M
KURAKura Oncology Inc
US$ 9.9613
(-37.39%)
6.84M
SHOTWSafety Shot Inc
US$ 0.1001
(-33.27%)
2.5k
BLRXBioLineRx Ltd
US$ 0.37
(-32.13%)
4.96M
TMTCTMT Acquisition Corporation
US$ 4.66
(-27.64%)
12.11k
CDTConduit Pharmaceuticals Inc
US$ 0.1156
(25.24%)
463.61M
NVDANVIDIA Corporation
US$ 143.17
(-1.86%)
180.58M
AKTSAkoustis Technologies Inc
US$ 0.1049
(20.44%)
177.49M
ELABElevai Labs Inc
US$ 0.0203
(-5.14%)
115.33M
WORXSCWorx Corporation
US$ 1.9353
(97.48%)
99.94M

NXGL Discussion

Ver más
TrendTrade2016 TrendTrade2016 1 semana hace
NXGL...MY NEXT BIO BEAST READY TO ROAR THROUGH WALL STREET
👍️0
Monksdream Monksdream 2 semanas hace
NXGL, new 52 week high
👍️0
81vette 81vette 1 mes hace
Looks like flipping the warrents would have been good last few days
👍️0
Helter Skelter Helter Skelter 1 mes hace
Expecting earnings report around Nov 14th...🤪
👍️0
Helter Skelter Helter Skelter 1 mes hace
Hey 81vette, expecting earnings' NEWS any moment/day.
Also anticipating a PROFIT which should send $NXGL, I'm thinking...😺
👍️0
81vette 81vette 1 mes hace
Hey bro,good to see you,yes it’s been stairstepping up nicely since early 2023
Thanks for reminding me about it!!
👍️0
Helter Skelter Helter Skelter 1 mes hace
Looking for 100% gain from here (2.80) when earnings are released around Nov. 14, 2024.

As of August 13, 2024, the registrant had 6,324,266 shares of common stock outstanding.



$NXGL



👉️ NXGL 10Q Period Ending June 30, 2024
👍️0
Monksdream Monksdream 5 meses hace
NXGL under $3
👍️0
tdag910 tdag910 9 meses hace
Winner winner chicken dinner!!
👍️0
Pinksatthehotel Pinksatthehotel 9 meses hace
Looking good!
👍️0
tdag910 tdag910 1 año hace
Anybody home?
👍️0
alyck alyck 1 año hace
NXGL looking great! Solidly over $2 and volume increasing. Keep it going
👍️0
81vette 81vette 2 años hace
Ended @New 52 week high,blue sky babe!! Enjoy the weekend everyone!!
👍️0
81vette 81vette 2 años hace
contracts with pro sports teams will make brand huge,building a great company,investment in packaging plant was wise
👍️0
81vette 81vette 2 años hace
For the first quarter of 2023, revenue totaled $620 thousand and increased by $224 thousand, or 56.6%, compared to $396 thousand for the same period the year prior. The increase in overall revenues was primarily due to sales growth in both contract manufacturing and branded products. Revenue during the first quarter of 2023 includes one full month of revenue contribution from the Company’s newly formed joint venture with C.G. Laboratories.first quarter we delivered 56.6% revenue growth year-over-year, driven by increased sales in contract manufacturing and branded consumer products. We also started to see contribution in March from our new joint venture with CG Labs. During the quarter, we launched several new products and invested strategically in sales and marketing to support those launches. We are already starting to see the financial returns from these investments in the second quarter, as well as from our new JV.” “Based on the dynamic changes to our business, which include the March 1 joint venture, I feel it’s important to provide a one-time exception to our policy of not providing guidance. Based on these developments and our progress to date, we are projecting $1.0 million in revenue for the second quarter of 2023, an increase of 78.2% year-over-year. Complementing this, we had approximately $5.8 million in cash and cash equivalents at quarter-end, which gives us sufficient runway to operate and the ability to be opportunistic about further potential investments to accelerate our growth.”Acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business.
Executed a supply agreement with a large new customer relating to a new consumer product.Launched advertising and marketing initiative, which has increased branded product sales.
👍️ 1
81vette 81vette 2 años hace
watch demand,next move up thru 52 week high,very low supply atm
👍️0
81vette 81vette 2 años hace
GOLDEN CROSS is best indicator of long bulls,follow the money is the saying
👍️0
81vette 81vette 2 años hace
eps q/q up 60%,is why moving up,big profit coming,great future $ deals,expect institutions loading long,way undervalued@ 10M mkt cap
👍️0
81vette 81vette 2 años hace
GOLDEN CROSS now,thru triple top res.,52week high>$2.00,then blue sky
👍️0
81vette 81vette 2 años hace
4M float,5M o/s,.52%short,buy vol 15X ave,not optionable,shares borrow ava. dropped 400% with pre-mkt volume,easily could go ZERO BORROW with this low float/os
👍️0